Manoj Arra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Manoj Arra has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Yousef Abu-Amer
Department of Orthopedic Surgery Washington University School of Medicine St. Louis Missouri USA
2 shared publications Christopher Holthaus
Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri
1 shared publicationGabriel Mbalaviele
Bone and Mineral Division, Department of Medicine, Washington University School of Medicine, St. Louis, USA
1 shared publicationGaurav Swarnkar
Department of Orthopaedic Surgery and Cell Biology & Physiology, Washington University School of Medicine, St. Louis, USA
1 shared publicationJesse E. Otero
OrthoCarolina Hip and Knee Center, Charlotte, USA
1 shared publicationJie Shen
Department of Orthopaedic Surgery and Cell Biology & Physiology, Washington University School of Medicine, St. Louis, USA
1 shared publication
Latest Publications
- Open Access
- 6 June 2025
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 75, 79-88
Comparison of Initial Lactate Levels and Their Prognostic Utility in Obese and Nonobese Patients with Sepsis
- 6 June 2025
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 75, 79-88
Open AccessComparison of Initial Lactate Levels and Their Prognostic Utility in Obese and Nonobese Patients with Sepsis
- Top Cited Papers
- 22 April 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (8) , 1012-1021
Cross-talk of inflammation and chondrocyte intracellular metabolism in osteoarthritis
- 22 April 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (8) , 1012-1021
Top Cited PapersCross-talk of inflammation and chondrocyte intracellular metabolism in osteoarthritis
- Top Cited PapersOpen Access
- 9 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-16
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
The contribution of inflammation to the chronic joint disease osteoarthritis (OA) is unclear, and this lack of clarity is detrimental to efforts to identify therapeutic targets. Here we show that chondrocytes under inflammatory conditions undergo a metabolic shift that is regulated by NF-κB activation, leading to reprogramming of cell metabolism towards glycolysis and lactate dehydrogenase A (LDHA). Inflammation and metabolism can reciprocally modulate each other to regulate cartilage degradation. LDHA binds to NADH and promotes reactive oxygen species (ROS) to induce catabolic changes through stabilization of IκB-ζ, a critical pro-inflammatory mediator in chondrocytes. IκB-ζ is regulated bi-modally at the stages of transcription and protein degradation. Overall, this work highlights the function of NF-κB activity in the OA joint as well as a ROS promoting function for LDHA and identifies LDHA as a potential therapeutic target for OA treatment.
- 9 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-16
Top Cited PapersOpen AccessLDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
The contribution of inflammation to the chronic joint disease osteoarthritis (OA) is unclear, and this lack of clarity is detrimental to efforts to identify therapeutic targets. Here we show that chondrocytes under inflammatory conditions undergo a metabolic shift that is regulated by NF-κB activation, leading to reprogramming of cell metabolism towards glycolysis and lactate dehydrogenase A (LDHA). Inflammation and metabolism can reciprocally modulate each other to regulate cartilage degradation. LDHA binds to NADH and promotes reactive oxygen species (ROS) to induce catabolic changes through stabilization of IκB-ζ, a critical pro-inflammatory mediator in chondrocytes. IκB-ζ is regulated bi-modally at the stages of transcription and protein degradation. Overall, this work highlights the function of NF-κB activity in the OA joint as well as a ROS promoting function for LDHA and identifies LDHA as a potential therapeutic target for OA treatment.